vimarsana.com
Home
Live Updates
Instylla First-In-Human Clinical Trial Published Results Demonstrate Technical Success and Persistent Embolization Across All Patients : vimarsana.com
Instylla First-In-Human Clinical Trial Published Results Demonstrate Technical Success and Persistent Embolization Across All Patients
/PRNewswire/ -- Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the...
Related Keywords
Taiwan
,
Gerards Goh
,
Helen Kavnoudias
,
Jee Fu Huang
,
Andrew Holden
,
Markd Goodwin
,
Department Of Internal Medicine
,
Kaohsiung Medical University Hospital
,
Instylla Inc
,
Internal Medicine
,
East Asia
,
Embrace Hydrogel Embolic System
,
Phasei First
,
Human Study
,
Polyethylene Glycol Based Liquid Embolic
,
Benign Hypervascular Tumors
,
Interventional Radiology
,
Water Based Liquid Embolic
,
Rabbit Kidney Model
,
Instylla Sprig Consulting
,
vimarsana.com © 2020. All Rights Reserved.